Survival and Disease Progression According to Gender of Patients With HIV Infection: The Terry Beirn Community Programs for Clinical Research on AIDS
Objective.—To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV).Design.—Multicenter cohort.Setting.—Seventeen community-based centers participating in the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).Patients.—A t...
Saved in:
| Published in: | JAMA : the journal of the American Medical Association Vol. 272; no. 24; pp. 1915 - 1921 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Chicago, IL
American Medical Association
28-12-1994
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Objective.—To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV).Design.—Multicenter cohort.Setting.—Seventeen community-based centers participating in the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).Patients.—A total of 768 women and 3779 men enrolled in one or more of 11 protocols between September 7, 1990, and September 30, 1993.Main Outcome Measures.—Survival and opportunistic events.Results.—The median CD4+ cell count at enrollment into the cohort was 0.240 ×109/L (240/μL) for women and 0.137 ×109/L for men (P<.001). Compared with men, women were younger (36 vs 38 years), more likely to be African American or Hispanic (78% vs 44%), and more likely to have reported a history of injection drug use (49% vs 27%). Women had been followed up for a median of 14.5 months and men for 15.5 months. The adjusted relative risk (RR) for death among women compared with men was 1.33 (95% confidence interval [CI], 1.06 to 1.67; P=.01) and for disease progression (including death) was 0.97 (95% CI, 0.82 to 1.15; P=.72). Women were at increased risk for bacterial pneumonia (RR, 1.38; 95% CI, 1.05 to 1.92) and at reduced risk for the development of Kaposi's sarcoma (RR, 0.16; 95% CI, 0.04 to 0.65) and oral hairy leukoplakia (RR, 0.54; 95% CI, 0.31 to 0.94). The increased risk of death and bacterial pneumonia for women compared with men was primarily evident among those with a history of injection drug use (RR, 1.68 for death, 95% CI, 1.20 to 2.35, P=.003; RR, 1.53 for bacterial pneumonia, 95% CI, 1.03 to 2.29, P=.04). Among patients without a history of disease progression at entry, death was the first event reported for more women than men (27.5% vs 12.2%).Conclusions.—Compared with men, HIV-infected women in the CPCRA were at increased risk of death but not disease progression. Risks of most incident opportunistic diseases were similar for women and men; however, women were at an increased risk of bacterial pneumonia. These findings may reflect differential access to health care and standard treatments or different socioeconomic status and social support for women compared with men.(JAMA. 1994;272:1915-1921) |
|---|---|
| AbstractList | A study compared disease progression and mortality between women and men infected with HIV. Results indicate that, compared with men, HIV-infected women were at increased risk of death but not disease progression. To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV). Multicenter cohort. Seventeen community-based centers participating in the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). A total of 768 women and 3779 men enrolled in one or more of 11 protocols between September 7, 1990, and September 30, 1993. Survival and opportunistic events. The median CD4+ cell count at enrollment into the cohort was 0.240 x 10(9)/L (240/microL) for women and 0.137 x 10(9)/L for men (P < .001). Compared with men, women were younger (36 vs 38 years), more likely to be African American or Hispanic (78% vs 44%), and more likely to have reported a history of injection drug use (49% vs 27%). Women had been followed up for a median of 14.5 months and men for 15.5 months. The adjusted relative risk (RR) for death among women compared with men was 1.33 (95% confidence interval [CI], 1.06 to 1.67; P = .01) and for disease progression (including death) was 0.97 (95% CI, 0.82 to 1.15; P = .72). Women were at increased risk for bacterial pneumonia (RR, 1.38; 95% CI, 1.05 to 1.92) and at reduced risk for the development of Kaposi's sarcoma (RR, 0.16; 95% CI, 0.04 to 0.65) and oral hairy leukoplakia (RR, 0.54; 95% CI, 0.31 to 0.94). The increased risk of death and bacterial pneumonia for women compared with men was primarily evident among those with a history of injection drug use (RR, 1.68 for death, 95% CI, 1.20 to 2.35, P = .003; RR, 1.53 for bacterial pneumonia, 95% CI, 1.03 to 2.29, P = .04). Among patients without a history of disease progression at entry, death was the first event reported for more women than men (27.5% vs 12.2%). Compared with men, HIV-infected women in the CPCRA were at increased risk of death but not disease progression. Risks of most incident opportunistic diseases were similar for women and men; however, women were at an increased risk of bacterial pneumonia. These findings may reflect differential access to health care and standard treatments or different socioeconomic status and social support for women compared with men. OBJECTIVETo compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV).DESIGNMulticenter cohort.SETTINGSeventeen community-based centers participating in the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).PATIENTSA total of 768 women and 3779 men enrolled in one or more of 11 protocols between September 7, 1990, and September 30, 1993.MAIN OUTCOME MEASURESSurvival and opportunistic events.RESULTSThe median CD4+ cell count at enrollment into the cohort was 0.240 x 10(9)/L (240/microL) for women and 0.137 x 10(9)/L for men (P < .001). Compared with men, women were younger (36 vs 38 years), more likely to be African American or Hispanic (78% vs 44%), and more likely to have reported a history of injection drug use (49% vs 27%). Women had been followed up for a median of 14.5 months and men for 15.5 months. The adjusted relative risk (RR) for death among women compared with men was 1.33 (95% confidence interval [CI], 1.06 to 1.67; P = .01) and for disease progression (including death) was 0.97 (95% CI, 0.82 to 1.15; P = .72). Women were at increased risk for bacterial pneumonia (RR, 1.38; 95% CI, 1.05 to 1.92) and at reduced risk for the development of Kaposi's sarcoma (RR, 0.16; 95% CI, 0.04 to 0.65) and oral hairy leukoplakia (RR, 0.54; 95% CI, 0.31 to 0.94). The increased risk of death and bacterial pneumonia for women compared with men was primarily evident among those with a history of injection drug use (RR, 1.68 for death, 95% CI, 1.20 to 2.35, P = .003; RR, 1.53 for bacterial pneumonia, 95% CI, 1.03 to 2.29, P = .04). Among patients without a history of disease progression at entry, death was the first event reported for more women than men (27.5% vs 12.2%).CONCLUSIONSCompared with men, HIV-infected women in the CPCRA were at increased risk of death but not disease progression. Risks of most incident opportunistic diseases were similar for women and men; however, women were at an increased risk of bacterial pneumonia. These findings may reflect differential access to health care and standard treatments or different socioeconomic status and social support for women compared with men. Objective.—To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV).Design.—Multicenter cohort.Setting.—Seventeen community-based centers participating in the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).Patients.—A total of 768 women and 3779 men enrolled in one or more of 11 protocols between September 7, 1990, and September 30, 1993.Main Outcome Measures.—Survival and opportunistic events.Results.—The median CD4+ cell count at enrollment into the cohort was 0.240 ×109/L (240/μL) for women and 0.137 ×109/L for men (P<.001). Compared with men, women were younger (36 vs 38 years), more likely to be African American or Hispanic (78% vs 44%), and more likely to have reported a history of injection drug use (49% vs 27%). Women had been followed up for a median of 14.5 months and men for 15.5 months. The adjusted relative risk (RR) for death among women compared with men was 1.33 (95% confidence interval [CI], 1.06 to 1.67; P=.01) and for disease progression (including death) was 0.97 (95% CI, 0.82 to 1.15; P=.72). Women were at increased risk for bacterial pneumonia (RR, 1.38; 95% CI, 1.05 to 1.92) and at reduced risk for the development of Kaposi's sarcoma (RR, 0.16; 95% CI, 0.04 to 0.65) and oral hairy leukoplakia (RR, 0.54; 95% CI, 0.31 to 0.94). The increased risk of death and bacterial pneumonia for women compared with men was primarily evident among those with a history of injection drug use (RR, 1.68 for death, 95% CI, 1.20 to 2.35, P=.003; RR, 1.53 for bacterial pneumonia, 95% CI, 1.03 to 2.29, P=.04). Among patients without a history of disease progression at entry, death was the first event reported for more women than men (27.5% vs 12.2%).Conclusions.—Compared with men, HIV-infected women in the CPCRA were at increased risk of death but not disease progression. Risks of most incident opportunistic diseases were similar for women and men; however, women were at an increased risk of bacterial pneumonia. These findings may reflect differential access to health care and standard treatments or different socioeconomic status and social support for women compared with men.(JAMA. 1994;272:1915-1921) To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV). Multicenter cohort. Seventeen community-based centers participating in the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). A total of 768 women and 3779 men enrolled in one or more of 11 protocols between September 7, 1990, and September 30, 1993. Survival and opportunistic events. The median CD4 super(+) cell count at enrollment into the cohort was 0.240x10 super(9)/L (240/ mu L) for women and 0.137 x10 super(9)/L for men (P<.001). Compared with men, women were younger (36 vs 38 years), more likely to be African American or Hispanic (78% vs 44%), and more likely to have reported a history of injection drug use (49% vs 27%). Women had been followed up for a median of 14.5 months and men for 15.5 months. The adjusted relative risk (RR) for death among women compared with men was 1.33 (95% confidence interval [Cl], 1.06 to 1.67; P=.01) and for disease progression (including death) was 0.97 (95% Cl, 0.82 to 1.15; P=.72). Women were at increased risk for bacterial pneumonia (RR, 1.38; 95% Cl, 1.05 to 1.92) and at reduced risk for the development of Kaposi's sarcoma (RR, 0.16; 95% Cl, 0.04 to 0.65) and oral hairy leukoplakia (RR, 0.54; 95% Cl, 0.31 to 0.94). The increased risk of death and bacterial pneumonia for women compared with men was primarily evident among those with a history of injection drug use (RR, 1.68 for death, 95% Cl, 1.20 to 2.35, P=.003; RR, 1.53 for bacterial pneumonia, 95% Cl, 1.03 to 2.29, P=.04). Among patients without a history of disease progression at entry, death was the first event reported for more women than men (27.5% vs 12.2%). Compared with men, HIV-infected women in the CPCRA were at increased risk of death but not disease progression. Risks of most incident opportunistic diseases were similar for women and men; however, women were at an increased risk of bacterial pneumonia. These findings may reflect differential access to health care and standard treatments or different socioeconomic status and social support for women compared with men. |
| Author | Deyton, Lawrence R Holloway, William J Anastos, Kathryn Townley, David Morris, Amy Taylor, Victoria M Hardy, Michelle Capps, Linnea Creagh, Terri Link, Kurt El-Sadr, Wafaa Pablovich, Sue Godbey, Joel Scott, John Deyton, Lawrence Brown, Lawrence S Valuer, William Braithwaite, Jilleen Ellison, Jacquelyn Fisher, Evelyn Lee, Janet Lackman, Cheryl Mesard, Carol A Loveless, Mark DuChene, Alain Labriola, Ami Thompson, Greg Korvick, Joyce A Mastro-Polak, Diane Fairclough, Colleen Ebright, Jack Neaton, James D Wentworth, Deborah N Carlyn, Marcia Reves, Randall R Sheridan, Annemarie Johns, Stanley Walker, Janice Cohn, David L Kocher, Jeffrey Weisholtz, Steven Blatt, David Morris, Bea Markowitz, Norman Martinez, Norma Kerkering, Thomas M Renzetti, Renee Webster, Carol Kumi, Jones Thompson, Melanie Salveson, Catherine Simmons, Phyllis Saravolatz, Louis Clanon, Kathleen Verheggen, Rita Luskin-Hawk, Roberta Kimmel, Nancy Gibert, Cynthia Schuman, Paula Melnick, Sandra L Sanvffle, Jane Irvin, Karen Moore, David Torres, Ramon A Winslow, Dean Owen, William Swanson, Ka |
| Author_xml | – sequence: 1 givenname: Sandra L surname: Melnick fullname: Melnick, Sandra L – sequence: 2 givenname: Renslow surname: Sherer fullname: Sherer, Renslow – sequence: 3 givenname: Thomas A surname: Louis fullname: Louis, Thomas A – sequence: 4 givenname: David surname: Hillman fullname: Hillman, David – sequence: 5 givenname: Evelyn M surname: Rodriguez fullname: Rodriguez, Evelyn M – sequence: 6 givenname: Cheryl surname: Lackman fullname: Lackman, Cheryl – sequence: 7 givenname: Linnea surname: Capps fullname: Capps, Linnea – sequence: 8 givenname: Lawrence S surname: Brown fullname: Brown, Lawrence S – sequence: 9 givenname: Marcia surname: Carlyn fullname: Carlyn, Marcia – sequence: 10 givenname: Joyce A surname: Korvick fullname: Korvick, Joyce A – sequence: 11 givenname: Lawrence surname: Deyton fullname: Deyton, Lawrence – sequence: 12 givenname: Stanley surname: Johns fullname: Johns, Stanley – sequence: 13 givenname: Jacquelyn surname: Ellison fullname: Ellison, Jacquelyn – sequence: 14 givenname: Micheal J surname: Hickson fullname: Hickson, Micheal J – sequence: 15 givenname: Janet surname: Lee fullname: Lee, Janet – sequence: 16 givenname: Melanie surname: Thompson fullname: Thompson, Melanie – sequence: 17 givenname: Terri surname: Creagh fullname: Creagh, Terri – sequence: 18 givenname: Amy surname: Morris fullname: Morris, Amy – sequence: 19 givenname: Jerome surname: Ernst fullname: Ernst, Jerome – sequence: 20 givenname: Cathy surname: Pollard fullname: Pollard, Cathy – sequence: 21 givenname: Kathryn surname: Anastos fullname: Anastos, Kathryn – sequence: 22 givenname: Mordechai surname: Bar fullname: Bar, Mordechai – sequence: 23 givenname: Elizabeth surname: Doramajian fullname: Doramajian, Elizabeth – sequence: 24 givenname: David surname: Blatt fullname: Blatt, David – sequence: 25 givenname: David surname: Moore fullname: Moore, David – sequence: 26 givenname: Renee surname: Renzetti fullname: Renzetti, Renee – sequence: 27 givenname: Rita surname: Verheggen fullname: Verheggen, Rita – sequence: 28 givenname: Roberta surname: Luskin-Hawk fullname: Luskin-Hawk, Roberta – sequence: 29 givenname: Ramon A surname: Torres fullname: Torres, Ramon A – sequence: 30 givenname: David surname: Townley fullname: Townley, David – sequence: 31 givenname: Kathleen surname: Clanon fullname: Clanon, Kathleen – sequence: 32 givenname: Bea surname: Morris fullname: Morris, Bea – sequence: 33 givenname: William surname: Owen fullname: Owen, William – sequence: 34 givenname: Carol surname: Brosgart fullname: Brosgart, Carol – sequence: 35 givenname: Lawrence R surname: Crane fullname: Crane, Lawrence R – sequence: 36 givenname: Jack surname: Ebright fullname: Ebright, Jack – sequence: 37 givenname: Paula surname: Schuman fullname: Schuman, Paula – sequence: 38 givenname: William surname: Valuer fullname: Valuer, William – sequence: 39 givenname: Colleen surname: Fairclough fullname: Fairclough, Colleen – sequence: 40 givenname: William J surname: Holloway fullname: Holloway, William J – sequence: 41 givenname: Dean surname: Winslow fullname: Winslow, Dean – sequence: 42 givenname: Susan surname: Szabo fullname: Szabo, Susan – sequence: 43 givenname: Arlene surname: Bincsik fullname: Bincsik, Arlene – sequence: 44 givenname: Karen surname: Swanson fullname: Swanson, Karen – sequence: 45 givenname: David L surname: Cohn fullname: Cohn, David L – sequence: 46 givenname: Randall R surname: Reves fullname: Reves, Randall R – sequence: 47 givenname: Michael J surname: Grodesky fullname: Grodesky, Michael J – sequence: 48 givenname: Carol A surname: Mesard fullname: Mesard, Carol A – sequence: 49 givenname: Joan E surname: Gans fullname: Gans, Joan E – sequence: 50 givenname: Wafaa surname: El-Sadr fullname: El-Sadr, Wafaa – sequence: 52 givenname: Cheryl surname: Guity fullname: Guity, Cheryl – sequence: 53 givenname: Michelle surname: Hardy fullname: Hardy, Michelle – sequence: 54 givenname: Luis surname: Fuentes fullname: Fuentes, Luis – sequence: 55 givenname: Louis surname: Saravolatz fullname: Saravolatz, Louis – sequence: 56 givenname: Norman surname: Markowitz fullname: Markowitz, Norman – sequence: 57 givenname: Jones surname: Kumi fullname: Kumi, Jones – sequence: 58 givenname: Diane surname: Mastro-Polak fullname: Mastro-Polak, Diane – sequence: 59 givenname: Jill surname: Hutchinson fullname: Hutchinson, Jill – sequence: 60 givenname: Janice surname: Walker fullname: Walker, Janice – sequence: 61 givenname: Sue surname: Pablovich fullname: Pablovich, Sue – sequence: 62 givenname: Phyllis surname: Simmons fullname: Simmons, Phyllis – sequence: 63 givenname: Nancy surname: Kimmel fullname: Kimmel, Nancy – sequence: 64 givenname: Jeffrey surname: Kocher fullname: Kocher, Jeffrey – sequence: 65 givenname: Steven surname: Weisholtz fullname: Weisholtz, Steven – sequence: 66 givenname: Annemarie surname: Sheridan fullname: Sheridan, Annemarie – sequence: 67 givenname: Victoria M surname: Taylor fullname: Taylor, Victoria M – sequence: 68 givenname: Jilleen surname: Braithwaite fullname: Braithwaite, Jilleen – sequence: 69 givenname: James H surname: Sampson fullname: Sampson, James H – sequence: 70 givenname: Joel surname: Godbey fullname: Godbey, Joel – sequence: 71 givenname: Mark surname: Loveless fullname: Loveless, Mark – sequence: 72 givenname: Catherine surname: Salveson fullname: Salveson, Catherine – sequence: 73 givenname: Norma surname: Martinez fullname: Martinez, Norma – sequence: 74 givenname: Thomas M surname: Kerkering fullname: Kerkering, Thomas M – sequence: 75 givenname: Carol surname: Webster fullname: Webster, Carol – sequence: 76 givenname: Evelyn surname: Fisher fullname: Fisher, Evelyn – sequence: 77 givenname: Kurt surname: Link fullname: Link, Kurt – sequence: 78 givenname: Lawrence surname: Gernon fullname: Gernon, Lawrence – sequence: 79 givenname: Ami surname: Labriola fullname: Labriola, Ami – sequence: 80 givenname: Cynthia surname: Gibert fullname: Gibert, Cynthia – sequence: 81 givenname: John surname: Scott fullname: Scott, John – sequence: 82 givenname: Elizabeth surname: Finley fullname: Finley, Elizabeth – sequence: 83 givenname: Karen surname: Irvin fullname: Irvin, Karen – sequence: 84 givenname: James D surname: Neaton fullname: Neaton, James D – sequence: 85 givenname: Tim surname: Brelje fullname: Brelje, Tim – sequence: 86 givenname: Alain surname: DuChene fullname: DuChene, Alain – sequence: 87 givenname: Greg surname: Thompson fullname: Thompson, Greg – sequence: 88 givenname: Deborah N surname: Wentworth fullname: Wentworth, Deborah N – sequence: 89 givenname: Lawrence R surname: Deyton fullname: Deyton, Lawrence R – sequence: 90 givenname: Jane surname: Sanvffle fullname: Sanvffle, Jane – sequence: 91 givenname: Mary surname: Foulkes fullname: Foulkes, Mary |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3424813$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/7990243$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc1uEzEUhS1UVNLCA7BAshBiN8F_M7bZlRTaSJWoaIDlyPHcaRzN2K09UykPwvviIVEk2GAvvDjfuUfX5wyd-OABIUzJnBJCP2xNb-ZUazEnvGSECUIEJ1w_QzNaclXwUqsTNCNEq0IKJV6gs5S2JB_K5Sk6lVpnE5-hX3djfHJPpsPGN_jSJTAJ8G0M9xFScsHjC2tDbJy_x0PAV-AbiDi0-NYMDvyQ8E83bPD18gde-hbskC0f8WoDeAUx7vAncNHjRej70btht59s-oTbEPGic97ZnP0Ncm60GzzlLS_vXqLnrekSvDq85-j7l8-rxXVx8_Vqubi4KQyT5VBYYSpuGNGNrhpFFaNEGSUI0y1rK2U1VGsi9VoZPV2rpRLGCC0YiEqykp-j9_u5DzE8jpCGunfJQtcZD2FMtayULKVk_wVpJQXTUmTw7T_gNozR5yVqRiknjP2B1B6yMaQUoa0foutN3NWU1FO_9dRvPfVb_91vtr45zB_XPTRH46HQrL876Cbln22j8dalI8YFE4pO2Os9NuUcRSW05Pw3_MC3aA |
| CODEN | JAMAAP |
| ContentType | Journal Article |
| Copyright | 1995 INIST-CNRS Copyright American Medical Association Dec 28, 1994 |
| Copyright_xml | – notice: 1995 INIST-CNRS – notice: Copyright American Medical Association Dec 28, 1994 |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QP 7TK 7TS 7U7 7U9 8FD C1K FR3 H94 K9. M7N NAPCQ P64 RC3 7X8 |
| DOI | 10.1001/jama.1994.03520240043039 |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Nursing & Allied Health Premium Genetics Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
| DatabaseTitleList | Virology and AIDS Abstracts MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1538-3598 |
| EndPage | 1921 |
| ExternalDocumentID | 1679113 10_1001_jama_1994_03520240043039 7990243 3424813 384973 |
| Genre | Multicenter Study Research Support, U.S. Gov't, P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article Feature |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- -ET -~X .55 .GJ .XZ 0R~ 186 1CY 1KJ 1VV 29J 2CT 2FS 2KS 2WC 354 39C 3O- 4.4 53G 5GY 5RE 6TJ 85S AAIKC AAMNW AAQQT AAWTL AAYJJ ABCQX ABEFU ABEHJ ABIVO ABOCM ABPMR ABPPZ ABRSH ABWJO ACBNA ACGFS ACNCT ACPRK ACQAM ACTDY ADKLL ADUKH AETEA AFCHL AFFDN AFFNX AFHKK AFRAH AGFXO AGHSJ AHMBA AI. ALMA_UNASSIGNED_HOLDINGS AMJDE ARBJA C45 CJ0 CS3 EBS EJD EX3 F5P FA8 G8K GX1 J5H KOO L7B MVM N4W N9A NEJ NHB NYF OBH OCB OGEVE OHH OHT OMK OVD P-O P2P PQQKQ RAJ SJN TEORI TN5 UBC UBY UHB UHU UKR UPT VH1 VVN WH7 WOQ WOW X7M XJT XOL XZL YCJ YFH YHZ YOC YPV YQJ YQT YQY YR2 YXB YYM YYQ YZZ ZA5 ZCA ZGI ZKG ZXP 08R 0WA 18M 68V 9M8 AAOGT AAPBV AAUGY AAYOK ABBLC ABPTK ACCUC ADBBV AFDAS AFMIJ AKALU ANMPU BKOMP BRYMA D0S EAM EBD EMOBN F20 H13 HF~ IQODW KQ8 OK1 QJJ RNS S10 SKT SV3 UAP UMD WHG XHN XSW YQI YRY YSK ZCG ~H1 CGR CUY CVF ECM EIF NPM UIG AAYXX ABDPE CITATION 7QL 7QP 7TK 7TS 7U7 7U9 8FD C1K FR3 H94 K9. M7N NAPCQ P64 RC3 7X8 |
| ID | FETCH-LOGICAL-a275t-c4a63a209d96d8182108a84029f2f68c9e6b079b8a9a9a9c9784aa4942e467253 |
| ISSN | 0098-7484 |
| IngestDate | Thu Oct 24 23:20:51 EDT 2024 Fri Oct 25 09:25:19 EDT 2024 Thu Oct 10 22:04:43 EDT 2024 Thu Nov 21 23:33:23 EST 2024 Tue Oct 15 23:15:31 EDT 2024 Sun Oct 29 17:08:44 EDT 2023 Fri Jul 05 02:03:28 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 24 |
| Keywords | Infection Human Immunopathology Viral disease Sex Evolution AIDS Immune deficiency Survival |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a275t-c4a63a209d96d8182108a84029f2f68c9e6b079b8a9a9a9c9784aa4942e467253 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
| PMID | 7990243 |
| PQID | 211302274 |
| PQPubID | 42339 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_76875772 proquest_miscellaneous_16742974 proquest_journals_211302274 crossref_primary_10_1001_jama_1994_03520240043039 pubmed_primary_7990243 pascalfrancis_primary_3424813 ama_primary_384973 |
| PublicationCentury | 1900 |
| PublicationDate | 1994-12-28 |
| PublicationDateYYYYMMDD | 1994-12-28 |
| PublicationDate_xml | – month: 12 year: 1994 text: 1994-12-28 day: 28 |
| PublicationDecade | 1990 |
| PublicationPlace | Chicago, IL |
| PublicationPlace_xml | – name: Chicago, IL – name: United States – name: Chicago |
| PublicationSubtitle | The Journal of the American Medical Association |
| PublicationTitle | JAMA : the journal of the American Medical Association |
| PublicationTitleAlternate | JAMA |
| PublicationYear | 1994 |
| Publisher | American Medical Association |
| Publisher_xml | – name: American Medical Association |
| SSID | ssj0000137 |
| Score | 1.9295361 |
| Snippet | Objective.—To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV).Design.—Multicenter... To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV). Multicenter cohort. Seventeen... A study compared disease progression and mortality between women and men infected with HIV. Results indicate that, compared with men, HIV-infected women were... To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV). Multicenter cohort. Seventeen... OBJECTIVETo compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV).DESIGNMulticenter... |
| SourceID | proquest crossref pubmed pascalfrancis ama |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1915 |
| SubjectTerms | Adult AIDS-Related Opportunistic Infections - epidemiology AIDS/HIV Analysis of Variance Biological and medical sciences CD4 Lymphocyte Count Cohort Studies Disease Progression Female HIV HIV Infections - immunology HIV Infections - mortality HIV Infections - physiopathology Human immunodeficiency virus Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Male Medical research Medical sciences Mortality Risk Factors Risk-Taking Sex Factors Sexes Survival Rate United States - epidemiology |
| Title | Survival and Disease Progression According to Gender of Patients With HIV Infection: The Terry Beirn Community Programs for Clinical Research on AIDS |
| URI | http://dx.doi.org/10.1001/jama.1994.03520240043039 https://www.ncbi.nlm.nih.gov/pubmed/7990243 https://www.proquest.com/docview/211302274 https://search.proquest.com/docview/16742974 https://search.proquest.com/docview/76875772 |
| Volume | 272 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEBabFEqhlKZtyDZNq0Nvi4Mty5Z0TLsbtiXdHtaB3IxWa9PAYod9FPpD-n87I8mPLenrUAzGyEYCzafxjDTzDSFvE6MTVoYyEOWCBZwZFiiexEFiorKMuFFG2CK2czG7keMJnwwGTXXQru2_ShraQNaYOfsP0m47hQZ4BpnDHaQO97-S-3wHi_-rZwDwxy8uCssxcIy0QYfTZknVWEAZySQw7NkRrPpstyl4hU2cVnVu4zKyYr3-NnpX3K5t5DqmlYAB7-O7LKtDl2bpKYS-4FHExYfxfM8EBjU_asJJesQVvRyX7vzoZ_RYquBV5cu_z0ft1jVSTPoyzm2MUb1zBApZt2E7vV2t_J7vuNvwsMzFUZtA7pV4R4HaKnEmWA-tjPd0MnikSe__jgRw9_47ejULcNhzZIpFBjhkRXOES_t03bPP-eX11VWeTW6yA_KAgaZDRTv_OOvxl-2TtvpQspb26p5x-oy_3kp6fKc3MOWlq7Tya1fImkTZU_LE-zL0woHwiAyK6hl5-MlHazwn3xssUsAi9VikPSzSFot0W1OHRVqXtMEiRSxSwCLtsEgBi9RikVos0haLtMEiBSzSBou0wSKF8RCLL8j15SR7Pw18GZBAM5FsA8N1GmsWqqVKl2BfsiiUWvKQqZKVqTSqSBehUAupFV5GCcm15oqzAqwAlsTH5LCqq-IEJr8wapmWsTQLw9MFU5FUPIQOdMplWuohOYLJz-8c0UseS65EPCRRI4v2jSP7BtcZP0cp5vtSHJKzPaF1XXLGZQR9njZCzP1K2-QswigCJviQvGnfgrbHIzxdFfVuk2POEFO_-0KkWKJCsCE5dthohxZgeDIev_xj56fkUbfuXpHD7XpXnJGDzXL32sL7B8-E2W8 |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Multiple Vendors |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Survival+and+disease+progression+according+to+gender+of+patients+with+HIV+infection.+The+Terry+Beirn+community+programs+for+clinical+research+on+AIDS&rft.jtitle=JAMA+%3A+the+journal+of+the+American+Medical+Association&rft.au=Melnick%2C+S+L&rft.au=Sherer%2C+R&rft.au=Louis%2C+T+A&rft.au=Hillman%2C+D&rft.date=1994-12-28&rft.issn=0098-7484&rft.volume=272&rft.issue=24&rft.spage=1915&rft.epage=1921&rft_id=info:doi/10.1001%2Fjama.1994.03520240043039&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0098-7484&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0098-7484&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0098-7484&client=summon |